Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial

João Pedro Ferreira; Timothy Collier; Andrew L Clark; Mamas A Mamas; Hans-Peter Brunner-La Rocca; Stephane Heymans; Arantxa González; Fozia Z Ahmed; Johannes Petutschnigg; Blerim Mujaj; Joe Cuthbert; Philippe Rouet; Pierpaolo Pellicori; Beatrice Mariottoni; Franco Cosmi; Frank Edelmann; Lutgarde Thijs; Jan A Staessen; Mark Hazebroek; Job Verdonschot; Patrick Rossignol; Nicolas Girerd; John G Cleland; Faiez Zannad

doi:10.1093/ehjcvp/pvab031

Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial

João Pedro Ferreira^*, Timothy Collier, Andrew L Clark, Mamas A Mamas, Hans-Peter Brunner-La Rocca, Stephane Heymans, Arantxa González, Fozia Z Ahmed, Johannes Petutschnigg, Blerim Mujaj, Joe Cuthbert, Philippe Rouet, Pierpaolo Pellicori, Beatrice Mariottoni, Franco Cosmi, Frank Edelmann, Lutgarde Thijs, Jan A Staessen, Mark Hazebroek, Job VerdonschotPatrick Rossignol, Nicolas Girerd, John G Cleland, Faiez Zannad

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	149-156
Number of pages	8
Journal	European Heart Journal-Cardiovascular Pharmacotherapy
Volume	8
Issue number	2
Early online date	2 Apr 2021
DOIs	https://doi.org/10.1093/ehjcvp/pvab031
Publication status	Published - 16 Feb 2022

Keywords

Cardiovascular risk
Hypertension
Spironolactone
Renin
RESISTANT HYPERTENSION
TASK-FORCE
ALDOSTERONISM
PREVENTION
MANAGEMENT
FIBROSIS
IMPACT

Access to Document

10.1093/ehjcvp/pvab031

Cite this

Ferreira, J. P., Collier, T., Clark, A. L., Mamas, M. A., Rocca, H-P. B-L., Heymans, S., González, A., Ahmed, F. Z., Petutschnigg, J., Mujaj, B., Cuthbert, J., Rouet, P., Pellicori, P., Mariottoni, B., Cosmi, F., Edelmann, F., Thijs, L., Staessen, J. A., Hazebroek, M., ... Zannad, F. (2022). Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. https://doi.org/10.1093/ehjcvp/pvab031

Ferreira, João Pedro ; Collier, Timothy ; Clark, Andrew L ; Mamas, Mamas A ; Rocca, Hans-Peter Brunner-La ; Heymans, Stephane ; González, Arantxa ; Ahmed, Fozia Z ; Petutschnigg, Johannes ; Mujaj, Blerim ; Cuthbert, Joe ; Rouet, Philippe ; Pellicori, Pierpaolo ; Mariottoni, Beatrice ; Cosmi, Franco ; Edelmann, Frank ; Thijs, Lutgarde ; Staessen, Jan A ; Hazebroek, Mark ; Verdonschot, Job ; Rossignol, Patrick ; Girerd, Nicolas ; Cleland, John G ; Zannad, Faiez. / Spironolactone effect on the blood pressure of patients at risk of developing heart failure : an analysis from the HOMAGE trial. In: European Heart Journal-Cardiovascular Pharmacotherapy. 2022 ; Vol. 8, No. 2. pp. 149-156.

@article{dfc0ceee65a34995ac1e838abd061199,

title = "Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial",

keywords = "Cardiovascular risk, Hypertension, Spironolactone, Renin, RESISTANT HYPERTENSION, TASK-FORCE, ALDOSTERONISM, PREVENTION, MANAGEMENT, FIBROSIS, IMPACT",

author = "Ferreira, {Jo{\~a}o Pedro} and Timothy Collier and Clark, {Andrew L} and Mamas, {Mamas A} and Rocca, {Hans-Peter Brunner-La} and Stephane Heymans and Arantxa Gonz{\'a}lez and Ahmed, {Fozia Z} and Johannes Petutschnigg and Blerim Mujaj and Joe Cuthbert and Philippe Rouet and Pierpaolo Pellicori and Beatrice Mariottoni and Franco Cosmi and Frank Edelmann and Lutgarde Thijs and Staessen, {Jan A} and Mark Hazebroek and Job Verdonschot and Patrick Rossignol and Nicolas Girerd and Cleland, {John G} and Faiez Zannad",

note = "{\textcopyright} Published on behalf of the European Society of Cardiology. All rights reserved. {\textcopyright} The Author 2021. For permissions, please email: journals.permissions@oup.com.",

year = "2022",

month = feb,

day = "16",

doi = "10.1093/ehjcvp/pvab031",

language = "English",

volume = "8",

pages = "149--156",

journal = "European Heart Journal-Cardiovascular Pharmacotherapy",

issn = "2055-6837",

publisher = "Oxford University Press",

number = "2",

}

Ferreira, JP, Collier, T, Clark, AL, Mamas, MA, Rocca, H-PB-L , Heymans, S, González, A, Ahmed, FZ, Petutschnigg, J, Mujaj, B, Cuthbert, J, Rouet, P, Pellicori, P, Mariottoni, B, Cosmi, F, Edelmann, F, Thijs, L, Staessen, JA, Hazebroek, M, Verdonschot, J, Rossignol, P, Girerd, N, Cleland, JG & Zannad, F 2022, 'Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 2, pp. 149-156. https://doi.org/10.1093/ehjcvp/pvab031

Spironolactone effect on the blood pressure of patients at risk of developing heart failure : an analysis from the HOMAGE trial. / Ferreira, João Pedro; Collier, Timothy; Clark, Andrew L; Mamas, Mamas A; Rocca, Hans-Peter Brunner-La ; Heymans, Stephane; González, Arantxa; Ahmed, Fozia Z; Petutschnigg, Johannes; Mujaj, Blerim; Cuthbert, Joe; Rouet, Philippe; Pellicori, Pierpaolo; Mariottoni, Beatrice; Cosmi, Franco; Edelmann, Frank; Thijs, Lutgarde; Staessen, Jan A; Hazebroek, Mark; Verdonschot, Job; Rossignol, Patrick; Girerd, Nicolas; Cleland, John G; Zannad, Faiez.

In: European Heart Journal-Cardiovascular Pharmacotherapy, Vol. 8, No. 2, 16.02.2022, p. 149-156.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Spironolactone effect on the blood pressure of patients at risk of developing heart failure

T2 - an analysis from the HOMAGE trial

AU - Ferreira, João Pedro

AU - Collier, Timothy

AU - Clark, Andrew L

AU - Mamas, Mamas A

AU - Rocca, Hans-Peter Brunner-La

AU - Heymans, Stephane

AU - González, Arantxa

AU - Ahmed, Fozia Z

AU - Petutschnigg, Johannes

AU - Mujaj, Blerim

AU - Cuthbert, Joe

AU - Rouet, Philippe

AU - Pellicori, Pierpaolo

AU - Mariottoni, Beatrice

AU - Cosmi, Franco

AU - Edelmann, Frank

AU - Thijs, Lutgarde

AU - Staessen, Jan A

AU - Hazebroek, Mark

AU - Verdonschot, Job

AU - Rossignol, Patrick

AU - Girerd, Nicolas

AU - Cleland, John G

AU - Zannad, Faiez

PY - 2022/2/16

Y1 - 2022/2/16

KW - Cardiovascular risk

KW - Hypertension

KW - Spironolactone

KW - Renin

KW - RESISTANT HYPERTENSION

KW - TASK-FORCE

KW - ALDOSTERONISM

KW - PREVENTION

KW - MANAGEMENT

KW - FIBROSIS

KW - IMPACT

U2 - 10.1093/ehjcvp/pvab031

DO - 10.1093/ehjcvp/pvab031

M3 - Article

C2 - 33822033

VL - 8

SP - 149

EP - 156

JO - European Heart Journal-Cardiovascular Pharmacotherapy

JF - European Heart Journal-Cardiovascular Pharmacotherapy

SN - 2055-6837

IS - 2

ER -